| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| RETA | REATA PHARMACEUTICALS INC | Loewen Andrea | SVP, Global Regulatory Affairs | Sep 14, 2023 | Sale | $172.03 | 3,175 | 546,181 | 28,416 | Sep 18, 2023, 05:34 PM | |
| RETA | REATA PHARMACEUTICALS INC | Loewen Andrea | SVP, Global Regulatory Affairs | May 12, 2023 | Sale | $86.26 | 6,750 | 582,267 | 32,007 | May 16, 2023, 04:17 PM | |
| RETA | REATA PHARMACEUTICALS INC | Loewen Andrea | SVP, Global Regulatory Affairs | May 15, 2023 | Sale | $84.71 | 103 | 8,725 | 31,904 | May 16, 2023, 04:17 PM | |
| RETA | REATA PHARMACEUTICALS INC | Loewen Andrea | SVP, Global Regulatory Affairs | May 16, 2023 | Sale | $81.02 | 313 | 25,359 | 31,591 | May 16, 2023, 04:17 PM | |
| RETA | REATA PHARMACEUTICALS INC | Loewen Andrea | SVP, Global Regulatory Affairs | Mar 07, 2023 | Sale | $58.70 | 34,036 | 1,997,937 | 57,793 | Mar 09, 2023, 04:47 PM | |
| RETA | REATA PHARMACEUTICALS INC | Loewen Andrea | SVP, Global Regulatory Affairs | Mar 03, 2023 | Sale | $87.73 | 1,601 | 140,456 | 42,793 | Mar 06, 2023, 04:44 PM | |
| RETA | REATA PHARMACEUTICALS INC | Loewen Andrea | SVP, Global Regulatory Affairs | Mar 02, 2023 | Sale | $90.61 | 218 | 19,753 | 44,394 | Mar 06, 2023, 04:44 PM |
Menu